Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lobeck

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Hepatology (Baltimore, Md.)|November 1, 1992
Hepatitis C virus reinfection in allografts after orthotopic liver transplantationV König, J Bauditz, H Lobeck, et al.
Clinical Transplantation|June 1, 1995
The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?A R Mueller, K P Platz, G Blumhardt, et al.
Transplantation Proceedings|February 1, 1995
The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine AA R Mueller, K P Platz, G Blumhardt, et al.
Transplantation Proceedings|June 24, 1998
Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantationJ Klupp, W O Bechstein, J Pratschke, et al.
Transplantation Proceedings|February 1, 1995
Analysis of risk factors for recurrence of hepatocellular carcinoma after orthotopic liver transplantationR Lohmann, W O Bechstein, J M Langrehr, et al.
Klinische Padiatrie|March 20, 2010
[Skin abscesses in kindergarten children: severe courses due to Panton-Valentine leukocidin producing S. aureus]A Kola, K Hübschmann, E-S Behl, et al.
Transplantation Proceedings|December 1, 1996
Incidence and outcome of chronic rejection in CyA- and FK 506-treated patientsK P Platz, S G Tullius, A R Mueller, et al.
Journal of Hepatology|January 1, 1990
Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV)U Hopf, B Möller, D Küther, et al.
Abdominal Imaging|May 1, 1996
MRI diagnosis and staging of rectal carcinomaW Pegios, J Vogl, M G Mack, et al.
Transplantation Proceedings|February 1, 1997
Impact of immunosuppression and acute rejection on hepatitis B recurrenceK P Platz, A R Mueller, G W Haller, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Hepatology (Baltimore, Md.)|November 1, 1992
Hepatitis C virus reinfection in allografts after orthotopic liver transplantationV König, J Bauditz, H Lobeck, et al.
Clinical Transplantation|June 1, 1995
The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?A R Mueller, K P Platz, G Blumhardt, et al.
Transplantation Proceedings|February 1, 1995
The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine AA R Mueller, K P Platz, G Blumhardt, et al.
Transplantation Proceedings|June 24, 1998
Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantationJ Klupp, W O Bechstein, J Pratschke, et al.
Transplantation Proceedings|February 1, 1995
Analysis of risk factors for recurrence of hepatocellular carcinoma after orthotopic liver transplantationR Lohmann, W O Bechstein, J M Langrehr, et al.
Klinische Padiatrie|March 20, 2010
[Skin abscesses in kindergarten children: severe courses due to Panton-Valentine leukocidin producing S. aureus]A Kola, K Hübschmann, E-S Behl, et al.
Transplantation Proceedings|December 1, 1996
Incidence and outcome of chronic rejection in CyA- and FK 506-treated patientsK P Platz, S G Tullius, A R Mueller, et al.
Journal of Hepatology|January 1, 1990
Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV)U Hopf, B Möller, D Küther, et al.
Abdominal Imaging|May 1, 1996
MRI diagnosis and staging of rectal carcinomaW Pegios, J Vogl, M G Mack, et al.
Transplantation Proceedings|February 1, 1997
Impact of immunosuppression and acute rejection on hepatitis B recurrenceK P Platz, A R Mueller, G W Haller, et al.
Pageof 14